SimplePractice Launches Customer Advisory Board
The Board is a group of established clinicians, researchers, industry advisors, and thought leaders dedicated to the mental health field...
Year: 2024
KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the...
Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
ASAP Translate Launches Dynamic Website for Optimal User Experience
ASAP Translate Unveils Advanced Website Redesign to Elevate User Experience PROVO, Utah, July 26, 2024 /PRNewswire/ -- ASAP Translate, a...
Specialty Enzymes Market to Surpass USD 10.4 Billion by 2034, Growing at a 6.4% CAGR: Digital Technologies and Automation Drive Efficiency and Cost Reduction | TMR
Growing consumer awareness of enzyme benefits fuels demand for enzyme-based products in various health and wellness sectors. WILMINGTON, Del., July...
ZUMBA FITNESS AND SAMSUNG HEALTH LAUNCH DYNAMIC PARTNERSHIP TO ELEVATE GLOBAL FITNESS AND WELLBEING
MIAMI, July 26, 2024 /PRNewswire/ -- Zumba®, the world-renowned dance fitness brand, and Samsung Health, a leading innovator in digital...
Clearly, a Ukrainian Startup for Psychological Support, Receives Funding from Google
KYIV, Ukraine, July 26, 2024 /PRNewswire/ -- Psychological Startup Clearly, originating from Ukraine, secures non-dilutive funding from Google for Startups Ukraine...
Pusan National University Researchers Explore the Interplay Between High-Affinity DNA and Carbon Nanotubes
Researchers demonstrate the intricate interactions between single-stranded DNA sequences and carbon nanotubes BUSAN, South Korea, July 26, 2024 /PRNewswire/ --...
Toronto Raptors and Canada Basketball Star RJ Barrett Teams with Aires Tech As Newest #AiresAthletes Partner
TORONTO, July 26, 2024 /PRNewswire/ -- American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) ("Aires Tech" or "Aires"), a pioneer in...
TMRW Life Sciences Offers 2024 United States Summer Olympic & Paralympic Teams Free Cryostorage for Frozen Embryos, Eggs & Sperm at State-of-the-Art Biorepository
NEW YORK, July 26, 2024 /PRNewswire/ -- TMRW Life Sciences (TMRW), a fertility technology company setting a new standard of...
Medical Oxygen Concentrators Market to Reach USD 7.1 Billion by 2034, Growing at a 6.9% CAGR: Surge in Demand for Sustainable and Cost-Effective Solutions Drives Market Growth | TMR
According to the latest medical oxygen concentrators market trends, Asia Pacific held largest share in 2023. Rise in prevalence of...
Avantor® Reports Second Quarter 2024 Results
Net sales of $1.70 billion, decrease of 2.4%; organic decline of 2.0%Net income of $93 million; Adjusted EBITDA of $306...
OmniGuide Holdings Announces Successful Completion of Patient Study for Revolutionary iSTONE(TM) Laser-Guided Lithotripsy Technology
BILLERICA, MA / ACCESSWIRE / July 26, 2024 / OmniGuide Holdings, Inc. (OGH) is thrilled to announce the successful completion...
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency
Southlake, TX, July 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the...
Allarity Therapeutics Announces Postponement of Annual Stockholders Meeting
Boston (July 26, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to...
ProMIS Neurosciences Reports Positive Top-Line Data from its Phase 1a Alzheimer’s Trial
Topline results demonstrated a favorable safety profile and tolerability across four ascending dose levels in healthy volunteers and showed dose...
OneMedNet Announces $4.6 Million Private Placement
Institutional investors include affiliates of Off the Chain Capital and Discovery Capital ManagementMINNEAPOLIS, July 26, 2024 (GLOBE NEWSWIRE) -- OneMedNet...
ProMIS Neurosciences Announces Up to $122.7 Million Private Placement Financing
$30.3 million financing upfront with up to an additional $92.4 million tied to exercise of warrants, with certain of the...
Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference
Presentation to feature Silo’s novel therapeutics for the underserved SARASOTA, FL, July 26, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc....
CHMP recommends RYBREVANT®▼ (amivantamab) in combination with chemotherapy for the treatment of adult patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC) after failure of prior therapy
Patients with EGFR ex19del or EGFR L858R mutations, the most common EGFR mutations in NSCLC, currently face a poor prognosis...